CR20140350A - ENRICHED COMPOSITIONS WITH OMEGA 3 POLYINSATURED FATTY ACIDS DPA IN A FREE ACID FORM - Google Patents

ENRICHED COMPOSITIONS WITH OMEGA 3 POLYINSATURED FATTY ACIDS DPA IN A FREE ACID FORM

Info

Publication number
CR20140350A
CR20140350A CR20140350A CR20140350A CR20140350A CR 20140350 A CR20140350 A CR 20140350A CR 20140350 A CR20140350 A CR 20140350A CR 20140350 A CR20140350 A CR 20140350A CR 20140350 A CR20140350 A CR 20140350A
Authority
CR
Costa Rica
Prior art keywords
fatty acids
free acid
polyinsatured
omega
acid form
Prior art date
Application number
CR20140350A
Other languages
Spanish (es)
Inventor
Timothy J Maines
Bernardus N M Machielse
Bharat M Mehta
Gerald Wisler
Michael Davidson
Peter Ralph Wood
Original Assignee
Omthera Pharmaceuticals Inc
Chrysalis Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2013/020398 external-priority patent/WO2013103902A1/en
Application filed by Omthera Pharmaceuticals Inc, Chrysalis Pharma Ag filed Critical Omthera Pharmaceuticals Inc
Publication of CR20140350A publication Critical patent/CR20140350A/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se presentan composiciones farmacéuticas enriquecidas en DPA de ácidos grasos poliinsaturados en forma de ácido libre, métodos terapéuticos para su uso y procesos para refinar las composiciones de aceite de pescado. También se proporcionan métodos de tratar la hipertrigliceridemia (200 mg/dl - 500 mg/dl) mediante la administración como adyuvante de una estatina y las composiciones farmacéuticas descritas en el presente documentoPharmaceutical compositions enriched in DPA of polyunsaturated fatty acids in the form of free acid, therapeutic methods for their use and processes for refining fish oil compositions are presented. Methods of treating hypertriglyceridemia (200 mg / dl - 500 mg / dl) are also provided by administration as an adjuvant of a statin and the pharmaceutical compositions described herein.

CR20140350A 2012-01-06 2014-07-22 ENRICHED COMPOSITIONS WITH OMEGA 3 POLYINSATURED FATTY ACIDS DPA IN A FREE ACID FORM CR20140350A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261583796P 2012-01-06 2012-01-06
US201261664047P 2012-06-25 2012-06-25
US201261669940P 2012-07-10 2012-07-10
PCT/US2013/020398 WO2013103902A1 (en) 2012-01-06 2013-01-04 Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form

Publications (1)

Publication Number Publication Date
CR20140350A true CR20140350A (en) 2015-02-23

Family

ID=53547797

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140350A CR20140350A (en) 2012-01-06 2014-07-22 ENRICHED COMPOSITIONS WITH OMEGA 3 POLYINSATURED FATTY ACIDS DPA IN A FREE ACID FORM

Country Status (1)

Country Link
CR (1) CR20140350A (en)

Similar Documents

Publication Publication Date Title
ECSP14012527A (en) DPA-ENRICHED COMPOSITIONS OF POLYINSATURATED OMEGA 3 FATTY ACIDS IN FREE ACID FORM
MX2022010507A (en) METHODS TO REDUCE THE RISK OF CARDIOVASCULAR EVENT IN SUBJECT WITH STATIN THERAPY.
CL2016003041A1 (en) Isolated double stranded ribonucleic acids, pharmaceutical compositions comprising them and method for inhibiting the expression of the alas1 gene based on the administration of said composition. divisional application 2725-2014.
CR20160212A (en) COMPOSITIONS AND METHODS TO MODULATE X-FARNESOID RECEPTORS
CO7240369A2 (en) Novel 5-aminotetrahydroquinolin-2-carboxylic acid and its use
EA200970374A1 (en) TREATMENT WITH ANTIARRHYTHMIC DRUGS AND OMEGA-3 FATTY ACIDS AND THEIR COMBINED PRODUCTS
GT201000182A (en) DOSAGE REGIME ASSOCIATED WITH INJECTABLE PALIPERIDONE ESTERS OF PROLONGED ACTION
CL2013000063A1 (en) A method of treating a subject comprising administering optionally deuterated n-ethyl-n-phenyl1,2-dihydroxy-4-hodroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, for the treatment of a disease autoimmune; a mixture thereof; Pharmaceutical composition and its preparation process.
MX352328B (en) ORAL ESTER FORMULATIONS OF TESTOSTERONE AND METHODS FOR THE TREATMENT OF THE DEFICIENCY OF TESTOSTERONE THAT INCLUDES THESE.
BR112014013175A2 (en) amphipathic lipid-based prolonged release compositions
PE20142367A1 (en) IMIQUIMOD FORMULATIONS
BR112013004440A2 (en) method for parenteral administration of a composition, pharmaceutical composition for parenteral administration, kit and pharmaceutical system for parenteral administration
EA201400152A1 (en) MICROORGANISMS THAT PRODUCE EICOPAPENNA ACID, COMPOSITIONS CONTAINING FATTY ACIDS, AND METHODS FOR THEIR RECEIVING
UY32937A (en) COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY
UA113962C2 (en) PHARMACEUTICAL COMPOSITION CONTAINING APOMORPHINE AS AN ACTIVE INGREDIENT
CO6910186A2 (en) Use of omega fatty acids for the treatment of diseases
CY1123942T1 (en) OMEGA-3 FATTY ACID COMPOSITIONS FOR THE TREATMENT OF DISEASES CAUSING DAMAGE TO THE NERVOUS SYSTEM
BR112014011744A2 (en) sustainable action formulation of cyclosporine form 2
BR112015030431A2 (en) modified release formulation
BR112016028561A8 (en) composition and dosage form comprising a marine oil comprising fatty acids, and use thereof
CR20140350A (en) ENRICHED COMPOSITIONS WITH OMEGA 3 POLYINSATURED FATTY ACIDS DPA IN A FREE ACID FORM
MX2016013680A (en) Methods and compositions for treatment of lipid storage disorders.
CL2013002237A1 (en) Arches comprising unsaturated etheric lipids; lipid composition obtained therefrom; method to obtain etheric lipids.
UA115639U (en) METHOD OF TREATMENT OF PATIENTS WITH NON-ALCOHOLIC LIVER DISEASE AND HYPERTONIC DISEASE
CR20120535A (en) ORAL FORMULATIONS OF ESTER OF TESTOSTERONE AND METHODS FOR THE TREATMENT OF THE DEFICIENCY OF TESTOSTERONE THAT INCLUDES THESE